Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

What happened to Darvon? It wasn’t addicting and didn’t cost much, and I never heard any reason why it was withdrawn except that “it didn’t work.” It sure ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The man, who authorities allege sold fentanyl laced oxycontin that caused the overdose death of a Duluth woman in 2023, was ...

Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...

This is a guest editorial by CNHI columnist . Cooney is a columnist for the Traverse City (Michigan) Record-Eagle. Reach her at [email protected]. Opioid abuse tells a tragic American story ...